TipRanks
Mega Genomics Limited (HK:6667)
:6667
Hong Kong Market
6667
Mega Genomics Limited
RESEARCH TOOLSreports
Want to see HK:6667 full AI Analyst Report?

Mega Genomics Limited (6667) Ratios

0 Followers

Mega Genomics Limited Ratios

HK:6667's free cash flow for Q2 2026 was ¥0.33. For the 2026 fiscal year, HK:6667's free cash flow was decreased by ¥ and operating cash flow was ¥0.15. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 25Dec 23Dec 22
Liquidity Ratios
Current Ratio
 3.56 ― 3.64 5.84 7.62
Quick Ratio
 3.41 ― 3.44 5.80 7.58
Cash Ratio
 2.07 ― 2.08 4.53 4.92
Solvency Ratio
 0.18 ― 0.19 0.30 -0.03
Operating Cash Flow Ratio
 <0.01 ― -0.08 1.43 -0.09
Short-Term Operating Cash Flow Coverage
 0.11 ― -7.94 85.61 0.00
Net Current Asset Value
¥ 505.29M¥ ―¥ 506.00M¥ 516.06M¥ 531.38M
Leverage Ratios
Debt-to-Assets Ratio
 0.03 ― 0.04 0.06 0.02
Debt-to-Equity Ratio
 0.05 ― 0.05 0.08 0.02
Debt-to-Capital Ratio
 0.04 ― 0.05 0.07 0.02
Long-Term Debt-to-Capital Ratio
 0.03 ― 0.03 0.03 0.00
Financial Leverage Ratio
 1.37 ― 1.36 1.24 1.14
Debt Service Coverage Ratio
 3.61 ― 12.86 15.25 -2.25
Interest Coverage Ratio
 19.55 ― 29.40 16.51 3.51
Debt to Market Cap
 0.02 ― 0.01 0.01 0.00
Interest Debt Per Share
 0.15 ― 0.16 0.23 0.06
Net Debt to EBITDA
 -9.14 ― -7.77 -8.96 71.73
Profitability Margins
Gross Profit Margin
33.73%―47.49%58.36%56.08%
EBIT Margin
7.71%―13.83%24.65%-14.20%
EBITDA Margin
12.17%―20.10%34.65%-3.72%
Operating Profit Margin
7.71%―15.83%12.24%1.73%
Pretax Profit Margin
8.62%―13.28%23.91%-14.70%
Net Profit Margin
6.90%―10.93%19.85%-12.09%
Continuous Operations Profit Margin
6.90%―10.93%19.85%-12.09%
Net Income Per EBT
79.98%―82.31%83.03%82.26%
EBT Per EBIT
111.82%―83.90%195.29%-847.57%
Return on Assets (ROA)
2.96%―3.25%3.77%-2.50%
Return on Equity (ROE)
4.04%―4.42%4.66%-2.85%
Return on Capital Employed (ROCE)
4.39%―6.19%2.72%0.40%
Return on Invested Capital (ROIC)
3.46%―5.03%2.21%0.33%
Return on Tangible Assets
2.96%―3.25%3.78%-2.50%
Earnings Yield
1.97%―2.12%1.52%-0.74%
Efficiency Ratios
Receivables Turnover
 1.47 ― 1.09 1.22 0.79
Payables Turnover
 1.44 ― 0.94 1.59 1.84
Inventory Turnover
 7.49 ― 3.29 14.29 18.25
Fixed Asset Turnover
 5.95 ― 3.65 1.61 2.93
Asset Turnover
 0.43 ― 0.30 0.19 0.21
Working Capital Turnover Ratio
 0.68 ― 0.47 0.28 0.25
Cash Conversion Cycle
 45.15 ― 57.39 95.27 284.72
Days of Sales Outstanding
 249.09 ― 333.73 298.80 462.92
Days of Inventory Outstanding
 48.72 ― 111.07 25.54 20.01
Days of Payables Outstanding
 252.66 ― 387.41 229.07 198.21
Operating Cycle
 297.81 ― 444.81 324.34 482.93
Cash Flow Ratios
Operating Cash Flow Per Share
 <0.01 ― -0.08 0.77 -0.03
Free Cash Flow Per Share
 <0.01 ― -0.08 0.60 -0.06
CapEx Per Share
 <0.01 ― <0.01 0.17 0.03
Free Cash Flow to Operating Cash Flow
 0.90 ― 1.01 0.78 1.75
Dividend Paid and CapEx Coverage Ratio
 0.04 ― -104.58 4.53 -1.33
Capital Expenditure Coverage Ratio
 10.21 ― -104.58 4.53 -1.33
Operating Cash Flow Coverage Ratio
 0.03 ― -0.56 3.37 -0.63
Operating Cash Flow to Sales Ratio
 <0.01 ― -0.07 1.08 -0.05
Free Cash Flow Yield
0.06%―-1.31%6.46%-0.51%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 51.29 ― 49.75 66.66 -134.41
Price-to-Sales (P/S) Ratio
 3.84 ― 5.17 13.06 16.25
Price-to-Book (P/B) Ratio
 2.06 ― 2.09 3.06 3.83
Price-to-Free Cash Flow (P/FCF) Ratio
 1.59K ― -76.55 15.49 -195.72
Price-to-Operating Cash Flow Ratio
 1.31K ― -77.28 12.07 -342.65
Price-to-Earnings Growth (PEG) Ratio
 -2.05 ― -1.22 -0.25 1.10
Enterprise Value Multiple
 22.44 ― 17.93 28.74 -365.10
Enterprise Value
 971.87M ― 890.69M 1.51B 1.98B
EV to EBITDA
 22.44 ― 17.93 28.74 -365.10
EV to Sales
 2.73 ― 3.60 9.96 13.58
EV to Free Cash Flow
 1.13K ― -53.40 11.81 -163.58
EV to Operating Cash Flow
 1.02K ― -53.91 9.20 -286.38
Tangible Book Value Per Share
 2.95 ― 3.09 3.04 2.99
Shareholders’ Equity Per Share
 2.96 ― 3.09 3.04 3.00
Tax and Other Ratios
Effective Tax Rate
 0.20 ― 0.18 0.17 0.18
Revenue Per Share
 1.74 ― 1.25 0.71 0.71
Net Income Per Share
 0.12 ― 0.14 0.14 -0.09
Tax Burden
 0.80 ― 0.82 0.83 0.82
Interest Burden
 1.12 ― 0.96 0.97 1.03
Research & Development to Revenue
 0.05 ― 0.07 0.16 0.13
SG&A to Revenue
 0.21 ― 0.25 0.50 0.53
Stock-Based Compensation to Revenue
 0.00 ― 0.00 0.05 0.03
Income Quality
 0.04 ― -0.50 5.45 0.32
Currency in CNY